文献速递神经介入外周血管MRDSA

3T四维MR血管成像与DSA在脑硬脑膜动静脉瘘栓塞术后随访中的比较:双中心研究

Assessment of 4D MR Angiography at 3T Compared with DSA for the Follow-up of Embolized Brain Dural Arteriovenous Fistula: A Dual-Center Study.
PubMed 文献 · AJNR Am J Neuroradiol · 2020-12-17

双中心回顾性分析44例栓塞治疗的硬脑膜动静脉瘘患者共51对检查,以DSA为参考标准评估3T四维对比增强MRA诊断效能。四维MRA检测残留/复发瘘的敏感度63.6%、特异度96.6%,观察者间及两种方法间一致性良好,但敏感度不足以替代血管造影。

要点

  • 3T四维对比增强MRA检测残留/复发硬脑膜动静脉瘘敏感度63.6%、特异度96.6%。
  • 四维MRA与DSA检测瘘及出血风险分层的两种方法间一致性良好(κ=0.60)。
  • 四维MRA敏感度不足以替代血管造影,随访仍需DSA确认。

核心结论

  • 3T四维对比增强MRA对栓塞治疗的硬脑膜动静脉瘘随访有价值,但敏感度不足以替代血管造影。

研究设计与样本

  • 双中心研究,纳入2008至2019年间因硬脑膜动静脉瘘接受栓塞治疗、且DSA与四维对比增强MRA间隔小于6个月的患者。
  • 共分析44例患者(中位年龄65岁,范围25-81岁)的51对检查。
  • 两位阅片者先独立、后共识判读四维对比增强MRA图像,检测残留/复发瘘并按Cognard分级系统分级。
  • 以DSA为参考标准,计算观察者间及两种方法间检测残留瘘和出血风险分层(0-I-IIa;IIb-IIa+b-III-IV-V)的κ系数。

诊断标准与关键数值

  • 四维对比增强MRA检测残留/复发硬脑膜动静脉瘘的敏感度为63.6%(95%CI,40.7%-82.8%),特异度为96.6%(95%CI,82.2%-99.9%)。
  • 四维对比增强MRA检测残留/复发瘘的阳性预测值为93.3%(95%CI,68.1%-99.8%),阴性预测值为77.8%(95%CI,60.8%-89.9%)。
  • 检测残留瘘的观察者间一致性κ=0.8(95%CI,0.6-1),出血风险分层的观察者间一致性κ=0.8(95%CI,0.5-1)。
  • 检测瘘及出血风险分层的两种方法间一致性良好,κ=0.60(95%CI,0.3-0.8)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: 4D contrast-enhanced MRA in the follow-up of treated dural arteriovenous fistulas has rarely been evaluated. Our aim was to evaluate its diagnostic performance at 3T in the follow-up of embolized dural arteriovenous fistulas using DSA as the standard of reference.

MATERIALS AND METHODS: Patients treated for dural arteriovenous fistulas in 2 centers between 2008 and 2019 were included if they met the following criteria: 1) dural arteriovenous fistula embolization, and 2) follow-up imaging with <6 months between DSA and 4D contrast-enhanced MRA. Two readers reviewed the 4D contrast-enhanced MRA images, first independently, then in consensus to detect any residual/recurrent dural arteriovenous fistula and to grade cases according to the Cognard classification system. Interobserver and intermodality agreement for the detection of a residual dural arteriovenous fistula and stratification of bleeding risk (0-I-IIa; IIb-IIa+b-III-IV-V) was calculated using κ coefficients.

RESULTS: A total of 51 pairs of examinations for 44 patients (median age, 65 years; range, 25-81 years) were analyzed. Interobserver agreement for the detection and stratification of bleeding risk was, respectively, κ = 0.8 (95% CI, 0.6-1) and κ = 0.8 (95% CI, 0.5-1). After consensus review, the sensitivity and specificity of 4D contrast-enhanced MRA for the detection of residual/recurrent dural arteriovenous fistula was 63.6% (95% CI, 40.7%-82.8%) and 96.6% (95% CI, 82.2%-99.9%), respectively. The positive and negative predictive values of 4D contrast-enhanced MRA were 93.3% (95% CI, 68.1%-99.8%) and 77.8% (95% CI, 60.8%-89.9%). Intermodality agreement for the detection and stratification of bleeding risk was good, with κ = 0.60 (95% CI, 0.3-0.8).

CONCLUSIONS: 4D contrast-enhanced MRA at 3T is of interest in the follow-up of treated dural arteriovenous fistulas but lacks the sensitivity to replace arteriography.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Dissaux B, Eugène F, Ognard J, et al. Assessment of 4D MR Angiography at 3T Compared with DSA for the Follow-up of Embolized Brain Dural Arteriovenous Fistula: A Dual-Center Study. AJNR Am J Neuroradiol. 2020. PMID: 33334853. doi:10.3174/ajnr.A6903

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。